Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease
Fanni F. Geibl, Martin T. Henrich, Wolfgang H. Oertel
Journal of Neural Transmission (2019) Vol. 126, Iss. 4, pp. 377-396
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Determinants of seeding and spreading of α-synuclein pathology in the brain
Martin T. Henrich, Fanni F. Geibl, Lakshminarasimhan Harini, et al.
Science Advances (2020) Vol. 6, Iss. 46
Open Access | Times Cited: 80
Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents
Debapriya Garabadu, Nidhi Agrawal
NeuroMolecular Medicine (2020) Vol. 22, Iss. 2, pp. 314-330
Closed Access | Times Cited: 72
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
K. A. Jellinger
Journal of Neural Transmission (2019) Vol. 126, Iss. 8, pp. 933-995
Closed Access | Times Cited: 42
Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact
Rita R. Fagan, Patrick J. Kearney, Carolyn G. Sweeney, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 16, pp. 5229-5244
Open Access | Times Cited: 34
Presynaptic Gq-coupled receptors drive biphasic dopamine transporter trafficking that modulates dopamine clearance and motor function
Patrick J. Kearney, Nicholas C. Bolden, Elizabeth Kahuno, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 2, pp. 102900-102900
Open Access | Times Cited: 12
New Targets and New Technologies in the Treatment of Parkinson’s Disease: A Narrative Review
Nicola Montemurro, Nelida Aliaga, Pablo Graff, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8799-8799
Open Access | Times Cited: 17
MiRNA-1976 Regulates the Apoptosis of Dopaminergic Neurons by Targeting the PINK1 Gene
Feng Qiu, Yue Wu, Guojin Xie, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 2
Open Access | Times Cited: 10
Protective effect of sterubin against neurochemical and behavioral impairments in rotenone-induced Parkinson's disease
May Alqurashi, Fahad A. Al‐Abbasi, Muhammad Afzal, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 2
Near-infrared light-responsive, pramipexole-loaded biodegradable PLGA microspheres for therapeutic use in Parkinson's disease
Shuang Li, Jiaxin Liu, Ge Li, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 141, pp. 1-11
Closed Access | Times Cited: 18
Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
Chuan Ze Liu, Da Shuai Guo, Jian Jun, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 10
Hibiscetin attenuates oxidative, nitrative stress and neuroinflammation via suppression of TNF-α signaling in rotenone induced parkinsonism in rats
Sami I. Alzarea, Muhammad Afzal, Khalid Saad Alharbi, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 12, pp. 1710-1717
Open Access | Times Cited: 10
In silico prediction of parkinsonian motor deficits-related neurotoxicants based on the adverse outcome pathway concept
Hung-Lin Kan, Chun-Wei Tung, Shao-En Chang, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 12, pp. 3305-3314
Closed Access | Times Cited: 8
The mechanistic effects of acupuncture in rodent neurodegenerative disease models: a literature review
Boxuan Li, Shizhe Deng, Hailun Jiang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
The Beneficial Effect of Rice Bran Extract Against Rotenone-Induced Experimental Parkinson’s Disease in Rats
Sachin Kumar, Puneet Kumar
Current Molecular Pharmacology (2021) Vol. 14, Iss. 3, pp. 428-438
Closed Access | Times Cited: 11
Neuropharmaceutical Properties of Naringin Against Alzheimer's and Parkinson's Diseases
Sahar Poudineh, Maryam Poudineh, Tahere Ghotbi, et al.
Galen Medical Journal (2022) Vol. 11
Open Access | Times Cited: 7
Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster
Rita R. Fagan, Patrick J. Kearney, Dino Luethi, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7793-7802
Open Access | Times Cited: 8
Neuroprotective effect of butin against rotenone-induced Parkinson’s disease mediated by antioxidant and anti-inflammatory actions through paraoxonase-1-induction
Fahad A. Al‐Abbasi
Journal of Taibah University for Science (2022) Vol. 16, Iss. 1, pp. 944-953
Open Access | Times Cited: 5
The low dopamine hypothesis: A plausible mechanism underpinning residual urine, overactive bladder and nocturia (RON) syndrome in older patients
Rebecca Haddad, Jalesh N. Panicker, Irina Verbakel, et al.
Progrès en Urologie (2023) Vol. 33, Iss. 4, pp. 155-171
Open Access | Times Cited: 2
Reformative Effect of Daidzein on Motor Dysfunction Following Rotenone Injection in Ovariectomized Rats
Aanchal Verma, Ahsas Goyal
Revista Brasileira de Farmacognosia (2022) Vol. 32, Iss. 4, pp. 563-574
Closed Access | Times Cited: 3
Sleep deprivation induces late deleterious effects in a pharmacological model of Parkinsonism
Leonardo B. Lopes-Silva, Débora Maria Gomes Cunha, Alvaro C. Lima, et al.
Experimental Brain Research (2024) Vol. 242, Iss. 5, pp. 1175-1190
Closed Access
Three paradoxes related to the mode of action of pramipexole: The path from D2/D3 dopamine receptor stimulation to modification of dopamine-modulated functions
E. Szabadi
Journal of Psychopharmacology (2024) Vol. 38, Iss. 7, pp. 581-596
Closed Access
Neurochemical mechanisms of tremor in Parkinson’s disease
I.A. Putyatin, Nataliya Titova
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 11, pp. 64-64
Closed Access
Dopaminergic Neurons and Parkinson’s Disease: Current Status, Implications and Future Perspectives
Fangze Tong
Highlights in Science Engineering and Technology (2023) Vol. 36, pp. 614-620
Closed Access | Times Cited: 1
AMI, an Indazole Derivative, Improves Parkinson’s Disease by Inhibiting Tau Phosphorylation
Mao Zhang, Zhu Wen-ting, Haitao Wang, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 2
Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact
Rita R. Fagan, Patrick J. Kearney, Carolyn G. Sweeney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top